Daiwa Securities Group Inc. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 62 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2024$3
+50.0%
1390.0%0.00%
Q4 2023$20.0%1390.0%0.00%
Q3 2023$20.0%1390.0%0.00%
Q2 2023$2
+100.0%
1390.0%0.00%
Q1 2023$1
-50.0%
1390.0%0.00%
Q4 2022$2
-99.8%
139
+131.7%
0.00%
Q3 2022$1,0000.0%600.0%0.00%
Q2 2022$1,0000.0%600.0%0.00%
Q1 2022$1,0000.0%600.0%0.00%
Q4 2021$1,0000.0%600.0%0.00%
Q3 2021$1,0000.0%600.0%0.00%
Q2 2021$1,0000.0%600.0%0.00%
Q1 2021$1,0000.0%600.0%0.00%
Q4 2020$1,0000.0%60
-48.7%
0.00%
Q3 2019$1,000
-50.0%
1170.0%0.00%
Q2 2019$2,0000.0%1170.0%0.00%
Q1 2019$2,0001170.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Birchview Capital, LP 30,000$560,1000.52%
ADIRONDACK TRUST CO 875$16,2660.01%
CWM, LLC 451$80.00%
BARCLAYS PLC 34,839$6500.00%
OSAIC HOLDINGS, INC. 623$11,6310.00%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders